fda banning tirzepatide 🚨 Important Update on Compounded 🚨, As of March 19th, the has officially banned compounded Tirzepatide formulations. We believe this is a huge disservice to patients seeking affordable The FDA Is About to

The addition of cannabis to a Wegovy regimen can provide mental health benefits, such as reducing anxiety and improving mood

4 Adverse events in PIONEER 3 1,4 Comparator AE rates are not an adequate basis for comparison of safety between products 1 Because clinical trials are conducted under widely varying conditions, AE rates observed in the clinical trials of a drug cannot be directly compared with rates in the clinical trials of another drug and may not reflect the rates observed in practice 1 AE=adverse event

These decisions honor your tolerability while maintaining once-weekly dosing structure

The missed expectations on Mounjaro and Zepbound sales compelled David Risinger of Leerink Partners to lower his firms 12-month price target on Lilly shares but only by 2%, from $990 to $970, though he maintained his firms Outperform rating on the stock